Davos26: Fresenius CEO laments patchwork of healthcare infrastructure
Amid a more politically charged healthcare landscape, Fresenius’ CEO has called for a “fundamental rethink” to deliver healthcare systems that…
20 Jan 2026
UK DRI announces trial of blood test for Alzheimer’s diagnosis
The UK Dementia Research Institute (DRI) has announced an international research study, which is underway to assess whether a finger-prick blood test could help diagnose Alzheimer’s disease before the onset…
20 Jan 2026
Guardant and MSD collaborate on companion diagnostics development
Guardant Health has entered a multi-year strategic partnership agreement with Merck & Co (MSD) for the development of companion diagnostics. The partnership will also focus on the commercialisation of new…
19 Jan 2026
FDA expands use of Organon’s contraception implant up to 5 years
Organon’s Nexplanon implant for preventing unwanted pregnancy can now be used for up to five years after the company gained US Food and Drug Administration (FDA) approval on a supplemental…
19 Jan 2026
JPM26: Medtech VC sees kidney care entering new era of innovation
A medtech VC firm said kidney care is emerging as a key focus area, citing a range of startups innovating in the space after attending this year’s J.P. Morgan Healthcare…
19 Jan 2026
Epiminder conducts first US implant of Minder epilepsy monitoring system
Epiminder has announced the first implantation of its Minder System in the US, a device developed for ongoing monitoring of epilepsy. The procedure took place at the Perelman School of…
19 Jan 2026
Zylox-Tonbridge to acquire German medical technology company Optimed
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology company Optimed. Under the agreement, Zylox-Tonbridge will acquire Optimed’s equity…